Nektar Therapeutics



Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform.

Gil M. Labrucherie
Jonathan Zalevsky
Chief Scientific Officer
John Northcott
SVP, Chief Commercial Officer
Jillian B. Thomsen
SVP, Finance & Chief Accounting Officer
Dimitry S.A. Nuyten
SVP, Chief Medical Officer
Mark A. Wilson
SVP, General Counsel
Jennifer Ruddock
SVP, Investor Relations & Corporate Affairs
Kevin Brodbeck
SVP, Manufacturing
Mary Tagliaferri
SVP, Executive Clinical Fellow
Urte Gayko
SVP, Drug Development & Regulatory Affairs
Brian L. Kotzin
SVP & Head of Immunology

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.